???pagination.result.count???
???pagination.result.page???
1
Alkyne-Bridged α-Conotoxin Vc1.1 Potently Reverses Mechanical Allodynia in Neuropathic Pain Models. , Belgi A., J Med Chem. March 25, 2021; 64 (6): 3222-3233.
A novel α-conopeptide Eu1.6 inhibits N-type (CaV2.2) calcium channels and exhibits potent analgesic activity. , Liu Z., Sci Rep. January 17, 2018; 8 (1): 1004.
Effects of arginine 10 to lysine substitution on ω-conotoxin CVIE and CVIF block of Cav2.2 channels. , Berecki G., Br J Pharmacol. July 1, 2014; 171 (13): 3313-27.
Isolation, synthesis and characterization of ω-TRTX-Cc1a, a novel tarantula venom peptide that selectively targets L-type Cav channels. , Klint JK., Biochem Pharmacol. May 15, 2014; 89 (2): 276-86.
Cloning and characterization of voltage-gated calcium channel alpha1 subunits in Xenopus laevis during development. , Lewis BB ., Dev Dyn. November 1, 2009; 238 (11): 2891-902.
Alternative splicing of the Ca2+ channel beta4 subunit confers specificity for gabapentin inhibition of Cav2.1 trafficking. , Mich PM., Mol Pharmacol. September 1, 2008; 74 (3): 904-12.
Human neuronal stargazin-like proteins, gamma2, gamma3 and gamma4; an investigation of their specific localization in human brain and their influence on CaV2.1 voltage-dependent calcium channels expressed in Xenopus oocytes. , Moss FJ., BMC Neurosci. September 23, 2003; 4 23.